With 25+ years of experience in the pharmaceutical industry, Jim Watson is at the intersection of cell and gene therapy and biomanufacturing. Watson shares how hiring people with a shared passion has enabled Project Farma to work on more than 100 life-changing therapies.

As a former life sciences executive, Kyp Sirinakis brings a unique perspective to her career in early stage venture investing. Sirinakis discusses her career and offers advice on how life sciences companies can prepare for success before approaching the capital markets.

Ken Mills discusses his four key ingredients to building a sustainable life sciences company, and why cultivating employees’ skills is critical to the future of life sciences innovation.

Rick Kohr has more than 30 years of experience in advising early-stage growth and middle-market companies on finance, recapitalization and exit strategies. Kohr shares what investors typically look for when considering new companies and what companies should prioritize when raising capital.

With a diverse background as an electrical engineer and investor, Troy LeMaile-Stovall leads TEDCO, the State of Maryland’s early-stage technology investing organization. Troy discusses how TEDCO seeks to help early-stage entrepreneurs overcome their natural shortages in time, talent, and treasure.

Mark Ajamian has contributed to remarkable growth in Maryland’s life sciences sector over his 25+ career in the life sciences industry and banking. Mark discusses the current state of capital markets, the macroeconomic environment, and the importance of being a good steward of capital.

Mike Gaffney has 30 years of experience in strategy development and execution, talent recruitment, business development, growth, and capital raising in health care and investing. In this episode, Gaffney shares the lessons he learned from in capital markets as both an investor and an executive.

Veteran PR executive David Warschawski shares the origin story of his successful PR firm, Warschawski, and the idea that sparked the creation of accelerator W Ventures.

Chris Sarlo, Founder of Life Science Wealth, discusses the unique wealth factors impacting biopharma founders and professionals and how his father’s cardiac event inspired him to serve the life sciences industry.